Be The First To
Theravance figures there's no sense in re-inventing the wheel. The biotechnology firm takes aim at already proven biological targets, taking advantage of previous years of research to create more effective, next-generation treatments. Its development programs focus on respiratory disease, bacterial infections, and gastrointestinal and neurological conditions. Its sole marketed product, VIBATIV (an injectable antibiotic approved to treat skin infections and hospital-acquired pneumonia) was successfully developed and commercialized with partner Astellas. In an exclusive...
This is the employer's chance to tell you why you should work for them. The information provided is from their perspective.
No Offer – Reviewed Nov 09, 2012
Interview Details Everyone there was really friendly and nice. Did a series of one-on-one or two-on-one interviews. Some of the interviewers seemed nervous or uncomfortable to be interviewing me. It's a small mellow company. I actually had not heard of them before coming across their job posting on this website… – Full Interview
Actually got no unexpected or difficult questions, which kind of turned me off as it seemed like the company was not serious in choosing a good candidate who can take on a challenge. Which makes me… – Answer Question
Let us know if we're missing any workplace or industry recognition –